Vor Biopharma VOR
NASDAQ VOR
$18.69 +0.63 (+3.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vor Biopharma (VOR) Selling, General & Administrative (2020 - 2026)

Updated

Vor Biopharma's Selling, General & Administrative was $21.93 million in Q2 2026, up 71.6% from $12.79 million a year earlier and up 24.9% from the prior quarter.

Analysis

Vor Biopharma (VOR) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vor Biopharma's Selling, General & Administrative was $70.23 million through Jun 30, 2026, up 119.2% year-over-year; for FY2025, it was $50.11 million, up 79.8% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $27.88 million in FY2024 (-12.1%), $31.72 million in FY2023 (+9.9%), $28.87 million in FY2022 (+34.3%) and $21.49 million in FY2021 (+82.9%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2020.
  • Compared with a year earlier, Selling, General & Administrative has increased for five straight quarters, with growth averaging 69.6% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2025 (growth of 181.2%); the worst was Q1 2025 (a decline of 17.7%).
  • Per Business Quant data, VOR's Selling, General & Administrative in the three quarters before Q2 2026 was $17.57 million (Q1 2026), $16.77 million (Q4 2025) and $13.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Vor Biopharma 983.47 Mn 983.47 Mn - 21.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.93 Mn
Mar 31, 2026 17.57 Mn
Dec 31, 2025 16.77 Mn
Sep 30, 2025 13.97 Mn
Jun 30, 2025 12.79 Mn
Mar 31, 2025 6.59 Mn
Dec 31, 2024 5.96 Mn
Sep 30, 2024 6.70 Mn
Jun 30, 2024 7.21 Mn
Mar 31, 2024 8.00 Mn
Dec 31, 2023 7.23 Mn
Sep 30, 2023 7.71 Mn
Jun 30, 2023 8.28 Mn
Mar 31, 2023 8.51 Mn
Dec 31, 2022 7.66 Mn
Sep 30, 2022 7.23 Mn
Jun 30, 2022 6.46 Mn
Mar 31, 2022 7.52 Mn
Dec 31, 2021 5.61 Mn
Sep 30, 2021 5.68 Mn
API Access

Vor Biopharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VOR&period=max&api_key=YOUR_API_KEY